Pioneer Trust Bank N A OR Buys 1,355 Shares of Danaher Co. (NYSE:DHR)

Pioneer Trust Bank N A OR grew its stake in shares of Danaher Co. (NYSE:DHR) by 4.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 34,340 shares of the conglomerate’s stock after buying an additional 1,355 shares during the period. Danaher makes up 2.4% of Pioneer Trust Bank N A OR’s portfolio, making the stock its 16th biggest position. Pioneer Trust Bank N A OR’s holdings in Danaher were worth $7,944,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of DHR. Wellington Management Group LLP raised its holdings in Danaher by 18.6% in the 3rd quarter. Wellington Management Group LLP now owns 24,930,281 shares of the conglomerate’s stock valued at $6,185,203,000 after acquiring an additional 3,905,449 shares in the last quarter. Northern Trust Corp raised its holdings in Danaher by 1.7% in the 3rd quarter. Northern Trust Corp now owns 8,100,722 shares of the conglomerate’s stock valued at $2,009,789,000 after acquiring an additional 134,905 shares in the last quarter. Flossbach Von Storch AG increased its stake in shares of Danaher by 1.8% in the 4th quarter. Flossbach Von Storch AG now owns 4,601,351 shares of the conglomerate’s stock valued at $1,064,477,000 after purchasing an additional 82,672 shares during the last quarter. Fisher Asset Management LLC increased its stake in shares of Danaher by 6.2% in the 4th quarter. Fisher Asset Management LLC now owns 4,227,108 shares of the conglomerate’s stock valued at $977,900,000 after purchasing an additional 248,140 shares during the last quarter. Finally, Invesco Ltd. increased its stake in shares of Danaher by 13.2% in the 3rd quarter. Invesco Ltd. now owns 4,070,455 shares of the conglomerate’s stock valued at $1,009,880,000 after purchasing an additional 473,693 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. TD Cowen lifted their price target on Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research note on Wednesday, April 24th. Citigroup boosted their price objective on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research report on Wednesday, April 24th. HSBC upgraded Danaher from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $250.00 to $280.00 in a research report on Wednesday, April 17th. Robert W. Baird boosted their price objective on Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 24th. Finally, Royal Bank of Canada upped their price target on Danaher from $254.00 to $282.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $267.31.

Danaher Stock Performance

Shares of DHR stock traded up $1.88 on Thursday, reaching $251.43. The stock had a trading volume of 1,505,798 shares, compared to its average volume of 2,712,004. The stock has a market cap of $186.23 billion, a P/E ratio of 42.51, a price-to-earnings-growth ratio of 3.82 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.51 and a current ratio of 1.85. The company has a 50 day simple moving average of $248.27 and a 200 day simple moving average of $233.19. Danaher Co. has a 1 year low of $182.09 and a 1 year high of $259.00.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.20. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The business’s revenue was down 2.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.36 earnings per share. Equities research analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.27 dividend. The ex-dividend date is Friday, June 28th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.43%. Danaher’s payout ratio is 18.31%.

Insider Buying and Selling

In other news, CEO Rainer Blair sold 47,175 shares of the company’s stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the transaction, the chief executive officer now directly owns 115,995 shares of the company’s stock, valued at $28,908,273.90. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, SVP Daniel Raskas sold 23,757 shares of Danaher stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the sale, the senior vice president now owns 38,102 shares of the company’s stock, valued at approximately $9,601,704. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Rainer Blair sold 47,175 shares of the business’s stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total value of $11,756,953.50. Following the completion of the sale, the chief executive officer now directly owns 115,995 shares in the company, valued at approximately $28,908,273.90. The disclosure for this sale can be found here. Insiders sold 103,984 shares of company stock valued at $25,997,094 over the last 90 days. Corporate insiders own 10.90% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.